Highlighting Pharmacodynamic Biomarkers of AD

SysQuant® Global Phosphoproteomics
TMTcalibrator™ Tissue-Enhanced Fluid Proteomics

Goal – Identify pharmacodynamic biomarkers in AD cerebrospinal fluid.     

Outcome – Common data outputs from SysQuant® and TMTcalibrator™ enabled the identification of pharmacodynamic biomarker candidates by comparing datasets from human clinical tissue, drug-treated animal tissues and human AD CSF samples.   

Collaborators University of Eastern Finland, Kuopio University Hospital, The Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital and Institute of Neurology, University College London

View all case studies